✍ Scribed by Philip J Johnson
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In this issue of Liver Transplantation two studies bring new data to the topic of living-donor transplantation (LDLT) for hepatocellular carcinoma (HCC), offering the opportunity for some comments. 1,2 Since LDLT became available, two concerns have puzzled hepatologists and surgeons involved with HC
We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no